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ABSTRACT
The Sleeping Beauty (SB) transposon is an advanced
tool for genetic engineering and a useful model to
investigate cut-and-paste DNA transposition in ver-
tebrate cells. Here, we identify novel SB transposase
mutants that display efficient and canonical excision
but practically unmeasurable genomic re-integration.
Based on phylogenetic analyses, we establish com-
pensating amino acid replacements that fully rescue
the integration defect of these mutants, suggesting
epistasis between these amino acid residues. We
further show that the transposons excised by the
exc+/int− transposase mutants form extrachromoso-
mal circles that cannot undergo a further round of
transposition, thereby representing dead-end prod-
ucts of the excision reaction. Finally, we demonstrate
the utility of the exc+/int− transposase in cassette
removal for the generation of reprogramming factor-
free induced pluripotent stem cells. Lack of genomic
integration and formation of transposon circles fol-
lowing excision is reminiscent of signal sequence re-
moval during V(D)J recombination, and implies that
cut-and-paste DNA transposition can be converted
to a unidirectional process by a single amino acid
change.
INTRODUCTION
DNA transposable elements, or transposons for short, are
mobile genetic elements capable of moving from one ge-
netic location to another in the genome. Most DNA trans-
posons are mobilized by a cut-and-paste transposition re-
action, that minimally requires a transposase protein and
the terminal inverted repeat (TIR) sequences of the trans-
poson. During transposition, the transposase (i) interacts
with its binding sites in the TIRs, (ii) promotes the assem-
bly of a synaptic complex, also called paired-end complex
(PEC), (iii) catalyzes excision of the element out of its donor
site and (iv) integrates the excised transposon at a new loca-
tion in target DNA. The majority of known transposases,
similarly to retroviral and retrotransposon integrases and
the RAG1 V(D)J recombinase, contain a highly conserved
aspartate-aspartate-glutamate (DDE) amino acid triad in
their RNaseH-type catalytic domains (1–4). These amino
acids play an essential role by coordinating Mg2+ ions re-
quired for the catalytic steps (DNA cleavage and joining) of
transposition (5,6).
The key biochemical step of all transposon excision re-
actions executed by DDE enzymes is the release of 3′-OH
groups at each transposon end, which are then used in the
strand transfer reaction during integration (7,8). First, a
single DNA strand is nicked by transposase-catalyzed hy-
drolysis of the phosphodiester bond in the DNA backbone
(7). During cut-and-paste transposition, nicking is followed
by cleavage of the complementary DNA strand resulting in
a double-strand break (DSB) that liberates the transposon
from the donor DNA (Supplementary Figure S1). To cat-
alyze second strand cleavage, DDE enzymes developed ver-
satile strategies (9–11).Most DDE transposases use a single
active site to cleave both DNA strands at one transposon
end via a DNA hairpin intermediate [reviewed in (11)] ei-
ther on the transposon end (12–15) or on the flanking donor
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DNA (16–20). Members of the Tc1/mariner family do not
transpose via a hairpin intermediate (21,22), indicating that
double-strand cleavage is the result of two sequential hy-
drolysis reactions by the transposase (23). The second step
of the transposition reaction is the transfer of the free 3′-OH
groups on the transposon ends to the target DNAmolecule
by transesterification. Similarly to the initial DNA cleavage,
strand transfer is executed by a nucleophilic attack. In this
case, the 3′-OH groups of the transposon serve as nucle-
ophiles, directly coupling the element to the target without
previous target DNA cleavage (Supplementary Figure S1).
Sleeping Beauty (SB) is a synthetic transposon that was
constructed based on sequences of transpositionally in-
active elements isolated from fish genomes (24). SB is a
Tc1/mariner superfamily transposon and follows a classi-
cal cut-and-paste transposition reaction. It supports a full
spectrum of genetic engineering applications/methods [re-
viewed in (25)] including the generation of transgenic cell
lines, induced pluripotent stem cell (iPSC) reprogramming
(26–31), phenotype-driven insertional mutagenesis screens
in the area of cancer biology [reviewed in (32–34)], germline
gene transfer in experimental animals (35–41) and somatic
gene therapy both ex vivo and in vivo [reviewed in (25,42–
48)].
In most of the genetic engineering applications high-
lighted above, permanent insertion of a transgene cassette
is required for long-term or even permanent expression of a
gene of interest. However, certain applications would bene-
fit from ‘transient transgenesis’, where presence and expres-
sion of a gene of interest is only transiently required. One
such paradigmatic application is the generation of iPSCs
with reprogramming transcription factors, where presence
of these factors is only required during reprogramming but
dispensable or even undesired once iPSCs are established.
Transient delivery of reprogramming factors can be accom-
plished by non-integrating vector systems (49) or by ge-
nomic integration of expression cassettes followed by their
excision, so as to result in genetically ‘clean’ but phenotypi-
cally altered cells. Indeed, reprogramming factor-free iPSCs
have been generated by applying components of the FLP-
and Cre-recombinase systems to either delete or exchange
the genomically integrated reprogramming factors (26,50).
One particular feature of transposon-based vectors is that
transposon excision is not always followed by re-integration
into a new genomic location. Thus, transposase-mediated
excision offers an opportunity for removal of the trans-
genes after completion of reprogramming. Transposition-
mediated generation of mouse and human iPSCs cells and
subsequent removal of the reprogramming factors from the
pluripotent cells by transient re-expression of the trans-
posase have already been achieved with the piggyBac (PB)
system (51,52). One caveat that still remains is the possibil-
ity of the transposon to jump into a new location during the
factor removal process. Indeed, it was estimated that ∼75%
of SB transposon excision events are followed by chromoso-
mal integration (53). A way to solve this problem would be
to develop a transposase that allows cutting but is deficient
in pasting.
Evidence for the excision and integration reactions being
separated in space and time came from mutational analy-
sis of the Tn10 transposase, which identified mutants that
were proficient in transposon excision but deficient in trans-
poson integration (exc+/int− phenotype) (54). Excised but
not reintegrated transposon molecules were also observed
during transposition of Tc1, Tc3 or Minos elements (55–
57). Recent mutational screening also identified PB trans-
posase mutants with an exc+/int− phenotype (58). Previous
alanine-scanning mutagenesis across the SB transposase
identified a mutant, K248A, which retained transposon ex-
cision activity but severely impaired re-integration (59). Un-
fortunately, excision efficiency of this mutant is greatly re-
duced, and it generates significantly more sequence hetero-
geneity at the excision sites than wild-type SB transposase,
which compromise its further use for precision genetic en-
gineering.
Here we systematically explored position 248 in the SB
transposase to gain further insight into the transposition
mechanism and to create novel mutants for genetic engi-
neering. The position of K248 in a target-capture structural
model of the SB transposase suggests that this amino acid
is involved in interaction with target DNA. Consistently,
we identify novel SB transposase mutants with a pheno-
type of efficient and precise excision and no measurable ge-
nomic re-integration. In the absence of integration, transpo-
son excision by these transposase mutants results in extra-
chromosomal circles that cannot undergo a further round
of transposition, thereby terminating the transposition re-
action. We demonstrate the utility of the exc+/int− trans-
posase in ‘transient transgenesis’ for the generation of re-
programming factor-free induced pluripotent stem cells.
MATERIALS AND METHODS
Phylogenetic sequence analyses
A diverse set of 76 transposase amino acid sequences en-
coded by Tc1 transposons was collected from transposons
described in the literature, reported in Repbase and iden-
tified by us in GenBank. We used FGENESH+ (60) to
predict the exon-intron structure of the Tc1 transposase
encoded by transposons reported in Repbase. The mul-
tiple alignment of the transposase amino acid sequences
was obtained by using MAFFT (61). The multiple align-
ment was edited manually by deletion of short variable N-
and C-terminal regions that do not constitute the Tc1 cat-
alytic core. The set of collected transposases is reported as
a supplemental file Tc1.fa, the full-length multiple align-
ment is reported as a supplemental file Tc1.mfa, the man-
ually edited multiple alignment used for the obtaining the
phylogenetic tree is reported as the Tc1 core1.mfa supple-
mental file. The phylogenetic tree was built by using PhyML
(62) (automatic model selection, Akaike information crite-
rion, SPR improvement with 5 random starting trees, aLRT
branch support). The same tree structure was supported by
different modifications of the PhyML parameters.
Structural modeling
The full-length Tn10 transposase structure wasmodeled us-
ing the crystal structure of the Tn5 transposase [Protein
Data Bank ID 1MUS; (63)] via Phyre2 (64,65) in intensive
mode. The SB target capture complex (TCC) model was as-
sembled based on the SB PEC homology model described
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in (66); the transposase catalytic domain was replaced with
the crystal structure (67), and target DNAwas modelled by
docking the integration target substrate from the PFV inta-
some structure [as in (67)]. Finally, the assembledmodel was
refined in HADDOCK (68). Structural models were visual-
ized using the PyMOL Molecular Graphics System (Ver-
sion 1.5.0.4, Schro¨dinger, LLC).
Site-directed mutagenesis of the SB100X transposase
All mutations were generated using the Q5 poly-
merase (NEB, Ipswich, MA, USA) and the plas-
mid pCMV(CAT)T7-SB100X (44). 5′-phosphorylated
primers for the particular positions were created with
‘NEBaseChanger™’ (http://nebasechanger.neb.com/) and
were designed with 5′-ends annealing back-to-back.
Primers were synthesized with a 5′-phosphate to enable
a downstream intramolecular ligation reaction and were
ordered from Eurofins (Eurofins/MWG, Luxembourg).
The primer sequences are listed in Supplemental Methods.
PCR cycling conditions were set according to the man-
ufacturer’s instructions. The annealing temperatures of
the mutagenic primers were calculated with the ‘NEB Tm
calculator™’ software (https://www.neb.com/tools-and-
resources/interactive-tools/tm-calculator). The PCR prod-
ucts were purified with QIAquick PCR Purification Kit
(QIAGEN, Venlo, Holland), eluted in 30 l elution buffer
and digested with 2 l DpnI (NEB, Ipswich, MA, USA)
for 2 h at 37◦C, followed by 20 min heat-inactivation at
80◦C.The linear, double-stranded PCR products were cir-
cularized by ligation with T4 DNA Ligase (NEB, Ipswich,
MA, USA) overnight at room temperature. The circu-
larized PCR products were transformed into chemically
competent E. coli (Invitrogen/Life Technologies, Carlsbad,
CA, USA), grown in Luria-Bertani (LB) medium for 1 h,
and selected for chloramphenicol resistance by plating on
LB agar plates containing 25 g/ml chloramphenicol. To
confirm the presence of the desired mutations, DNAs from
several single colonies were purified using the QIAprep
spin miniprep kit (QIAGEN, Venlo, Holland) and were
sequenced by GATC Biotech (Konstanz, Germany).
Western blotting
One day prior to transfection, 2 × 105 HeLa cells
were seeded onto six well plates.1.5 l of TransIT-
LT1transfection reagent (Mirus Bio LLC, Madison, WI,
USA) was used to transfect 500 ng of DNA (each trans-
fection reaction was filled up to 500 ng with the plasmid
pUC19). 50 ng of transposase plasmid [mutant SB100X
transposase or wild-type SB100X (pCMV(CAT)T7-
SB100X)] or green fluorescent protein (GFP) expression
plasmid (pmaxGFP™; Lonza, Basel, Switzerland) were
transfected. 48 h post transfection, HeLa cells were lysed
in RIPA buffer (150 mM NaCl, 1.0% Triton X-100,
1.0% Na-deoxycholate, 0.1% SDS, 25 mM Tris, pH 8.0)
supplemented with protease inhibitor cocktail (Complete
Mini, Roche, Basel, Switzerland). Protein was extracted
using the Bioruptor®Plus (Diagenode, Denville, NJ,
USA), 10 cycles, high power, 30 s ON/30 s OFF at 4◦C.
Total protein was quantified using BCA Protein Assay
Kit (Pierce, Rockford, IL, USA). Proteins (10 g per
lane) were loaded onto 10% polyacrylamide gels and
subjected to sodium dodecyl sulfate–polyacrylamide gel
electrophoresis. Gels were transferred to nitrocellulose
membrane (Hybond ECL, Amersham Bioscience, Little
Chalfont, UK) and immunoblotting was performed ac-
cording to standard procedures. Proteins were detected
with goat monoclonal anti-SB transposase antibody (R&D
Systems, Minneapolis, USA) at dilution 1:5000, or mouse
monoclonal anti-Vinculin antibody (Abcam, Cambridge,
UK) at dilution 1:3000, and chemiluminescence using ECL
Prime Western Blotting Detection Kit (Amersham Bio-
science). Signals were captured on a film (Hyperfilm ECL
High performance chemiluminescence film, Amersham
Bioscience, Little Chalfont, UK).
FACS-based excision assay
1.5 × 105 HeLa cells were seeded one day prior to trans-
fection. HeLa cells were transfected with 2 g of the trans-
poson donor plasmid pCMV(CAT)-GFP//T2Neo (67) and
200 ng of a mutant SB100X transposase, SB100X or a
catalytically inactive transposase mutant (E279D, here-
after called D3). As a GFP control we transfected 1 g
of an SB transposon expression plasmid for the green
fluorescent protein (GFP) (pT2.CAGGS.AmGFP trans-
poson; contains the GFP gene driven by the CAGGS
promoter). Six microliters of TransIT-LT1 transfection
reagent (Mirus Bio LLC, Madison, WI, USA) were used
per transfection reaction. Three days post-transfection
cells were trypsinized, washed with PBS, fixed in 1%
Paraformaldehyde (PFA) in PBS and FACS analyzed with
BD LSR II flow cytometer (BD Biosciences, Franklin
Lakes, NJ, USA). Data were analyzed with FCS Express
4 Flow Cytometry (De Novo Software, Glendale, CA).
The % GFP positive cells in cultures transfected with
SB100X transposasemutants/pCMV(CAT)-GFP//T2Neo
were normalized to that in cells transfected with wild-type
SB100X/pCMV(CAT)-GFP//T2Neo.
Transposition assay
For transposition assay in HeLa cells, 2 × 105 cells were
seeded onto six-well plates one day prior to transfec-
tion. Three microliters of TransIT-LT1transfection reagent
(Mirus Bio LLC, Madison, WI USA) was used to transfect
1 g of DNA (each transfection reaction was filled up to
1 g with the plasmid pUC19). To obtain predominantly
single-copy transposon insertions (69), 10 ng of transpo-
son donor plasmid (pT2B/puro) were co-transfected with
5 ng of transposase plasmid (mutant transposase, inactive
D3 transposase or SB100X). Forty-eight hours after trans-
fection cells were trypsinized and 2.5–5% of the cells were
replated to 10 cm plates and selected for transposon in-
tegration using 3 g/ml puromycin (InvivoGen, San Di-
ago, CA, USA). After 3 weeks of selection, cell colonies
were fixed with 10% (vol/vol) formaldehyde in phosphate-
buffered saline (PBS), stained with methylene blue in PBS,
and counted. For in vitro comparisons of relative transposi-
tion efficiencies at least three independent experiments were
performed.
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Single-copy transposon remobilization assay
For remobilization assays in HeLa cells, duplicates of 3 ×
105 cells were seeded onto six well plates one day prior
to transfection. Six microliters of TransIT-LT1 transfec-
tion reagent (Mirus Bio LLC, Madison, WI, USA) was
used to transfect 1 g of DNA (each transfection reac-
tion was filled up to 1 g with the plasmid pUC19). To
mobilize the SB transposon, 500 ng of plasmids express-
ing the mutant transposases K248S or K248T were trans-
fected. As controls 500 ng of pCMV(CAT)T7-SB100X or
500 ng plasmid expressing the D3 catalytically inactive SB
transposase were used. Forty-eight hours after transfec-
tion cells were trypsinized, replated to 10 cm plates and
selected for transposon excision using 3 g/ml puromycin
(InvivoGen, San Diago, CA, USA) or selected for transpo-
son integration after excision using 3 g/ml puromycin and
600 g/ml G418. After 3 weeks of selection, cell colonies
were fixed with 10% (vol/vol) formaldehyde in phosphate-
buffered saline (PBS), stained with methylene blue in PBS,
and counted. For in vitro comparisons of relative transposi-
tion efficiencies at least three independent experiments were
performed.
Transposon footprint analysis
These analyses were done essentially as decribed earlier
(22). 1 × 106 cultured HeLa cells were co-transfected with
5 g of a puromycin resistance gene-containing donor plas-
mid (pT2B/puro) or with the pCMV(CAT)-GFP//T2Neo
plasmid and 500 ng of either a mutant transposase expres-
sion plasmid, a plasmid expressing the SB100X transposase
(positive control) or a plasmid expressing the D3 catalyt-
ically inactive transposase mutant (negative control). Two
days post-transfection, cells were harvested, low molecular
weight DNA was isolated and digested with StyI overnight
at 37◦C (to get rid of the vector backbones). 2 l of digested
plasmids were added to a 50 l PCR reaction mixture con-
taining 1× Thermo buffer, 200 M dNTPs, 0.2 M for-
ward and reverse primer each and 1.25 units of Taq Poly-
merase (NEB). A series of PCR primers has been used for
nested excision products detecting PCR reactions. In the
first PCR round SB excision products were amplified us-
ing primers PUC2 and PUC5 (for pT2B/puro). The PCR
conditions were as follows: initial denaturation of 5 min at
95◦C, followed by 30 cycles of 30 s denaturation at 95◦C,
30 s annealing at 63◦C, 15 s elongation at 72◦C and a fi-
nal 5 min elongation at 72◦C. One l of a 1:50 dilution of
the first PCR product was used for the second round PCR
using nested primers PUC3 and PUC4. The composition
of the PCR mixture was otherwise the same. Nested PCR
was performed with 5 min initial denaturation at 95◦C, fol-
lowed by 30 cycles of 30 s denaturation at 95◦C, 30 s anneal-
ing at 65◦C, 15 s elongation at 72◦C and a final 5 min elon-
gation at 72◦C. For footprint analysis using pCMV(CAT)-
GFP//T2Neo first-round PCRs were done with primers
GFP-fw1 and GFP-rev1 and second round with GFP-fw2
and GFP-rev2 with initial denaturation 94◦C – 1 min fol-
lowed by 30 cycles of 94◦C – 30 s, 60◦C – 30 s and 68◦C – 15
s and final elongation 68◦C – 3 min.
For footprint analysis following transposon excision
from a genomic locus, 1.5 × 106 transgenic HepG2 and
HeLa cells harboring single-copy SB transposonswithin the
puromycin N-acetyl-transferase ORF (puro) were plated to
10 cm cell culture plates, and transfected with 3 g expres-
sion plasmids encoding the SB100X, K248S and K248T
transposases. Genomic DNA of the transfected cells was
isolated with the Quick-DNA Miniprep Kit (Zymo Re-
search) from cells with or without 1 g/ml puromycin se-
lection 5 days post-transfection. 500 ng of DNA was used
for amplifying the genomic excision sites using Q5 Poly-
merase (NEB) with GC enhancer with the PCR conditions:
98◦C 30 s; 30 cycles of 98◦C 10 s, 70◦C 30 s; 72◦C 2 min
with the primers puroRev0.5 and puroFw1. The PCR prod-
ucts were purified with the Clean and Concentrator Kit
(Zymo Research), eluted in 20 l and 1 l elute was used
for the nested PCR reaction with primers puroRev1.5 and
puroFw1.5 using the PCR program: 98◦C 30 s; 30 cycles of
98◦C 10 s, 68◦C 30 s; 72◦C 2 min. Amplification products
were separated by loading 10 l of the second PCR reac-
tion on a 1.5% agarose gel usingMidori Green staining. The
PCRproducts were cut out from the agarose gel, purified by
column (Zymo Research, Irvine, CA, USA) and cloned by
pGEM-T-Easy Vector Kit (Promega, Fitchburg, WI, USA)
or by the pJet PCR Cloning Kit (Thermo Fisher Scientific).
Colonies were picked and assayed by colony PCR ampli-
fying the ligated excision products. Colonies were resus-
pended in 10 l dH2O each and added to a 25 l PCR
reaction mixture containing 1× Standard buffer, 200 M
dNTPs, 1 mM MgCl2, 0.2 M T7 primer and SP6 primer
and 1.25 units of Taq Polymerase (NEB). The PCR con-
ditions were as followed: initial denaturation of 5 min at
94◦C, followed by 25 cycles of 30 s denaturation at 94◦C,
30 s annealing at 55◦C, 30 s elongation at 72◦C and a final 5
min elongation at 72◦C. PCR with primers pJet1.2Fw and
pJet1.2Rev were done using the Q5 polymerase and GC en-
hancer with the following conditions: 98◦C 30 s; 25 cycles
of 98◦C 10 s, 66◦C 10 s, 72◦C 30 s; 72◦C 2 min. Amplifica-
tion products were separated by loading the whole PCR re-
action on a 1.5% agarose gel using Midori Green staining.
The PCR products were cut out from the agarose gel and
purified by column (Zymo Research, Irvine, CA, USA) and
eluted in 12 l elution buffer. The purified PCR products
were sequenced using PUC3 primer (or with pJet1.2Fw).
Circle formation assay
HeLa cells were seeded in 10 cm petri dishes and trans-
fected with 500 ng of a transposase expression plasmid
(SB100X, K248S, K248T) and 5 g of the zeocin resistance
gene carrying transposon plasmid pT/zeo (70). Seventy two
hours post-transfection cells were washed twice with PBS,
trypsinized and the cell pellet was frozen overnight. The pel-
let was resuspended in 250 l resuspension buffer (50 mM
TrisHCl, 10 mM EDTA, 100 g/ml RNAse A) and lysed
by addition of 250 l lysis buffer (200 mMNaOH, 1% SDS
(w/v)). Through addition of 300 l neutralization buffer
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[3.0M potassium acetate (CH3CO2K) pH5.5] high molecu-
lar weight genomicDNAprecipitated. The supernatant was
removed and low molecular weight DNA was precipitated
with 0.8 vol isopropanol, washed with 70% ethanol and dis-
solved in 10 l 10 mM Tris pH 8. The extracted plasmid
DNA was subjected to restriction digestion with PvuII that
cleaves the original pT/zeo vector in the plasmid backbone,
but leaves transposon circles intact. The digested DNA was
purified by column (ZymoResearch, Irvine, CA,USA), and
electroporated into Top10 electrocompetent cells accord-
ing to manufacturer’s protocol. Bacteria were plated on LB
agar plates containing 20 g/ml zeocin directly after elec-
troporation to avoid clonal propagation of individual prod-
ucts in liquid culture. Twenty individual clones were an-
alyzed for circle formation by colony PCR. The colonies
were resuspended in 10 l dH2O and added to a 15 l PCR
reaction mixture containing 1x Standard buffer, 200 M
dNTPs, 1 mM MgCl2, 0.2 M SB IRDR R FW primer
and SB IRDR L RV primer each and 1.25 units of Taq
Polymerase (NEB). The PCR conditions were as follows:
initial denaturation of 5 min at 94◦C, followed by 25 cy-
cles of 30 s denaturation at 94◦C, 30 s annealing at 51◦C,
45 s elongation at 72◦C and a final 5 min elongation at
72◦C. Amplification products were separated by loading
the whole PCR reaction on a 2% agarose gel using Mi-
dori Green staining. DNA fragments were excised from the
agarose gel and purified using the Zymoclean™ Gel DNA
Recovery Kit. In the last step the DNA was eluted in 20 l
EB buffer (ZymoResearch) and sequenced for circle forma-
tion using SB IRDR R FW primer.
Work with iPSCs
Mouse iPSCs were cultured in knockout DMEM with
15% FBS, 2 mM L-glutamine, 1× nonessential amino acids,
0.1 mM 2-mercaptoethanol, 25 g/ml L-ascorbic acid and
10 ng/ml purified recombinant leukemia inhibitory factor
(LIF), and were were maintained onGeltrex™-coated plates
(Thermo Fisher; 1:100 dilution in DMEM F12). For trans-
fection, iPSCs were plated onto a six-well plate at a den-
sity of 2 × 105 per well one day prior to transfection. On
the following day, the cells were transfected with 10 g
of K248T transposase expression plasmid using Lipofec-
tamine 3000 transfection reagent (Thermo Fisher). Two
days after transfection, the cells were washed with PBS,
trypsinized with 400 l trypsin and centrifuged at 800 rpm
for 10 min. The supernatant was aspirated and the pellet
was resuspended in mouse iPSC medium with gently pipet-
ting in a total volume of 3 ml and transferred into pre-
warmed mouse iPSC medium in a 10 cm Geltrex™-coated
dish. Next day, the FIAU (Moravek Biochemicals) selec-
tion (200 ng/ml) was started. After selection for 2 weeks,
one surviving colony that expressed GFP was trypsinized,
picked mechanically and transferred to a Geltrex™-coated
10 cm dish. The cells were expanded for 5 days in mouse
iPS medium with FIAU and genomic DNA of the parental
iPSC line and the K248T ‘cassette-removed’ iPSC line was
isolated with DNeasy Blood & Tissue Kit (Qiagen, Venlo,
Netherlands). 1 g of samples were digested withDpnII for
18 h. 100 ng of the digested samples were ligated to DpnII-
splinkerette linkers (25 pmol) in 20 l reactions. Five mi-
croliters of the ligated DNA were used for the first PCR
with Linker Primer and T-Bal Rev with a cycle of 94◦C for
3 min, followed by 10 cycles of 94◦C for 30 s, ramp down
at 0.5◦C/s to 63◦C, anneal at 63◦C for 30 s and 1 min elon-
gation at 72◦C; After the first 10 cycles of PCR, a second
25 cycle amplification was performed with 94◦C for 30 s,
ramp down at 1◦C/s to 61◦C, anneal at 61◦C for 30 s, 1
min elongation at 72◦C and a final elongation at 72◦C for 10
min. 1 l of a 1:100 dilution of the first PCR was used for
nested PCR using primers Nested and T-Bal. Nested PCR
was performed with 3 min initial denaturation at 94◦C, fol-
lowed by 10 cycles of 94◦C for 30 s, ramp down at 1◦C/s
to 64◦C, anneal at 64◦C for 30 s and 1 min 30 s elongation
at 68◦C; After the first 10 cycles of PCR, a second 25 cy-
cle amplification was performed with 94◦C for 30 s, ramp
down at 1◦C/s to 60◦C, anneal at 61◦C for 20 s and 1 min
30 s elongation at 68◦C and a final elongation at 68◦C for
10 min.
For immunicytochemistry, parental and cassette-
removed iPSCs were seeded at a density of 1 × 105 cells per
well onto Nunc™ Lab-Tek™ 2-well Chambered Coverglass
(Thermo Fisher) coated with Geltrex™. On the following
day, cells were fixed with 4% paraformaldehyde solution
(Santa Cruz Biotechnology) and permeabilized with 0.1%
(v/v) Triton™ X-100 (Sigma-Aldrich). Slides were washed
three times with PBS and incubated with 5% (v/v) BSA
(Sigma-Aldrich) for 30 min at room temperature to block
unspecific binding. Slides were incubated with anti-nanog
antibody (rabbit polyclonal; Bethyl Laboratories) in 1%
(v/v) BSA for 2 h at room temperature. Slides were washed
4 times with 1% (v/v) BSA and incubated for 45 min in the
dark with anti-rabbit Alexa Fluor® 647 antibody (diluted
1:1000 in 1% (v/v) BSA; Thermo Fisher) and DAPI. Cells
were imaged with a Zeiss LSM 780 confocal microscope
(using a 20× objective) in the ALMF core facility at EMBL
Heidelberg.
RESULTS
The K248 group of Tc1 transposons
Earlier alanine-scanning mutagenesis found that the
K248A mutation in the SB transposase diminished trans-
poson integration (59). To explore the sequence diversity
at this position, we performed phylogenetic analysis and a
multiple sequence alignment of Tc1/mariner transposases.
This revealed that transposases containing lysines at
positions corresponding to SB’s K248 form a separate
group (called here the K248 group) (Figure 1A). In addi-
tion to the diagnostic K248, all K248 group transposase
sequences, including those encoded by transposons in
animals, land plants, fungi and protists, also contain
universally conserved D in position 246. The K248 group
can be subdivided into four subgroups that we named SB
(vertebrates), S (cnidarians, insects, hexapods, tardigrades
and planarians), Tc1 (insects and vertebrates) and FPP
(from fungi, plants and protists) (Figure 1A).
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Figure 1. Phylogeny of Tc1/mariner transposase amino acid sequences. (A) The maximum-likelihood phylogenetic tree obtained from the multiple align-
ment of the full-length transposase sequences by using PhyML is accompanied by a portion of the multiple alignment that corresponds to a region of the
SB transposase between amino acid positions 241 and 282. The numbers in the right column indicates the positions of the last shown amino acids in the
corresponding transposase sequences. Red asterisks mark the last two amino acid residues of the Tc1/mariner catalytic triad. The red oval indicates the
diagnostic position of the multiple alignment that corresponds to K248 in the SB transposase. All aLRT estimates of the bootstrap support values ≥0.9
are indicated by the numbers at the tree vertices. Different groups constituting the Tc1 clade are marked by rectangles of different colors. The mariner
clade transposases are marked by the green rectangle. The new K248 group of Tc1 transposases is marked by the yellow rectangle and red branches.
The Tc1–2Xt, Minos, Tc3, Bari and Impala groups of the Tc1 clade are marked by the purple, light-brown, blue, gray and pink rectangles, respectively.
The K248 group is composed of four subgroups called SB, S, Tc1 and FPP that are marked by the red, green, violet and blue vertical lines, respectively.
Transposon nomenclature, host species and GenBank accession numbers can be found in Supplementary Information. (B) SB transposase target capture
complex superimposed onto a Tn10 transposase model. SB is in green, Tn10 is in gray. Protein chains are shown in cartoon representation. K248 in SB and
Tn10 residues where mutations cause exc+/int− phenotype are shown in sticks representation with atomic coloring. (C) Location of K248 in the SB target
capture complex. Transposon and target DNA are shown as gray and black cartoon, respectively. The catalytic D244 residue and K248 are highlighted in
sticks representation. K248 is situated in close proximity to the target DNA.
Strong conservation of K248 in a particular group of
Tc1 transposases clearly implies functional importance of
this residue. Previously, a mutant screen identified 13 amino
acids in the Tn10 transposase that display an exc+/int− phe-
notype similar to that of the SB K248A mutant. Thus, to
compare the structural context of these protein residues,
we have modeled the Tn10 transposase structure and over-
laid this with the SB transposase target capture complex
(TCC). Tn10 was modelled based on the related bacterial
transposase Tn5 (63,71), and the SB TCC model was built
on the recently determined SB100X catalytic domain struc-
ture (66,67). Despite low sequence identity (<5%) between
the two transposases, their core RNaseH-fold superposes
well, with major differences restricted to the distinct inser-
tion domains (a beta-stranded domain in Tn5 and an ex-
tended clamp–loop in SB). Strikingly, K248 of SB overlaps
with a group of Tn10 mutations (A162, G163 and P167)
(Figure 1B) that have very severe defects in transposon inte-
gration (54). Notably, K248 is situated in close proximity to
target DNA in the SB TCCmodel, implying a role in target
binding and/or integration (Figure 1C). We conclude that
phylogenetic conservation and structural position imply a
fundamental role of K248 in transposon integration.
Saturation mutagenesis of K248 in the Sleeping
Beauty transposase identifies mutants with an excision-
proficient/integration-deficient phenotype
In order to assess the relative effects of single amino acid
replacements at position 248 on transposition, the SB100X
transposase was subjected to saturation mutagenesis by in-
corporating all possible amino acids by site-directed PCR
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mutagenesis. All constructs encoding mutant versions of
the SB100X transposase showed protein expression levels
equivalent to that of SB100X byWestern blot analysis (Sup-
plementary Figure S2).
We evaluated the mutants for their excision and full
transposition (excision + integration) activities relative to
SB100X in human cells. To measure transposon excision,
a FACS-based excision assay was performed. For this, we
transiently co-transfected plasmids expressing the different
transposases with a transposon donor construct, in which
a GFP coding sequence is disrupted by an SB transpo-
son. Precise excision of the SB transposon restores the GFP
ORF, leading to fluorescence that can be detected by FACS
analysis (67) (Figure 2A). The analysis revealed that all mu-
tations had a negative impact on excision activity; roughly
50% (10 out of 19) of themutants retained activity in a range
of 15–80% relative to SB100X, whereas the remaining 50%
(9 out of 19) displayed barely measurable activity or com-
plete loss of excision (Figure 2B). This is not suprising given
the strong conservation of lysine in this position across the
K248 group of Tc1 family transposases, as described above.
In order to assess the relative integration activity of each
transposase mutant, we performed a full transposition as-
say that is based on the generation of antibiotic-resistant
cell clones as a result of integration of antibiotic resistance
gene-carrying SB transposons fromdonor plasmids into the
chromosomes of transfected cells. Unexpectedly, the vast
majority (15 out of 19) of mutants displayed a complete loss
of function as defined by a colony forming potential similar
to a catalytically inactive DDE mutant, which was used as
negative control (Figure 2C). The data thus reveal a segre-
gation of transposon excision and integration activities with
two, arbitrarily defined clusters ofmutants: those that retain
≥60% excision activity of SB100X and show≥10% integra-
tion (K248C, K248I and K248V, P<0.01), and those that
retain 15–80% excision activity of SB100X, but show a com-
plete loss of integration (K248A, K248N, K248L, K248M,
K248S and K248T, P < 0.001 for excision and P < 0.01 for
integration).
From the excision-proficient, integration-deficient
(exc+/int−) mutants described above, K248S and K248T
displayed the highest excision rates (∼48% and ∼76%,
respectively, as compared to SB100X and measured by the
GFP-based assay) (Figure 2 and Supplementary Figure
S3). To further analyze the ability of these transposase
mutants to mobilize a single, chromosomally located
transposon, a transposon remobilization assay was used.
This assay is suitable for independent, quantitative scoring
of either excision or excision + integration activities of
SB transposases (Figure 3A). The remobilization assay
demonstrated that the K248S and K248T mutants are
able to excise a chromosomally integrated SB transposon
(K248S: ∼6%; K248T: ∼21% relative excision activity
compared to SB100X, P < 0.001), but fail to reintegrate
the excised transposon back into the genome (Figure
3B). In these assays, calculating with a 70% transfection
efficiency of the reporter cells, we estimate an excision rate
of 0.0068% and 0.023% per transfected cell for the K248S
and K248T mutants, respectively.
The D246A replacement rescues the integration-deficient
phenotype of K248 mutants
Our phylogenetic analysis shown in Figure 1A revealed
segregation of a distinct clade of transposases that do
not contain the D246/K248 dyad. In these transposases
the D246/K248 dyad is replaced by an A246[PICasv]248
dyad (where ‘PICasv’ represents six alternative amino acid
residues at position 248 with the most frequent residues P,
I and C in capital). These non-K248 transposons are rep-
resented by theMinos (insects and vertebrates), Tc3 (nema-
todes, insects, protists, crustaceans), Tc1–2Xt (vertebrates,
insects), Bari (fruit flies) and Impala (fungi) groups (Figure
1A), and by transposases from themariner clade and bacte-
rial transposases that are ancestral to the mariner and Tc1
clades (data not shown).
Because the non-K248 transposases invariably contain
A in position 246 (Figure 1A), we wondered if a D-to-A
replacement in position 246 of the SB transposase could
possibly rescue the integration defect in our exc+/int− mu-
tants. We introduced the D246A mutation into the newly
discovered K248S and K248T mutants and into the K248A
mutant described previously (59). Strikingly, the double-
mutant transposases displayed a full rescue of transposition
activity asmeasured by the colony-forming assay (Figure 4).
These results imply a cooperation between amino acids in
position 246 and 248 in SB transposition.
The K248S and K248T Sleeping Beauty transposase mutants
generate canonical excision footprints
DNA cleavage during transposon excision can occur at dif-
ferent positions relative to the transposon ends. Second
strand cleavage occurs directly opposite the first strand
cleavage site in V(D)J recombination (19) and for the bac-
terial Tn5 (72) and Tn10 elements (14), thereby generating
blunt ended products. In case of the Tc1/mariner elements
the non-transferred strand is cleaved a few nucleotides
inside the transposon (22,53,73–75), thereby generating
3′-overhangs (Supplementary Figure S1). The prominent
pathway for repairing transposon excision sites in somatic
mammalian cells is nonhomologous end-joining (NHEJ),
which generates transposon ‘footprints’ that are identical
to the first or last 2–4 nucleotides of the transposon in
Tc1/mariner transposition. Thus, canonical footprints gen-
erated by the SB transposase at the excision site are com-
posed of 7 bp-sequences, either 5′-TACAGTA-3′ or 5′-
TACTGTA-3′, comprising the terminal three base pairs of
the transposon flanked by TA dinucleotides (Supplemen-
tary Figure S1) (22,53). Although NHEJ repair predomi-
nantly produces canonical footprints after SB excisition in
zebrafish embryos (76), mouse embryonic stem cells (53),
Chinese hamster ovary cells (22) and somatic tissues of
transgenic mice (77), repair in mouse spermatids tends to
generate 1- and 2-bp footprints (78), and human HeLa cells
produce an even more significant footprint sequence diver-
sity (79,80). One likely explanation for dissimilar transpo-
son footprints in different cell types/species is cell type-
dependent variation in the activity of a critical host factor
involved in DSB repair after transposon excision.
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Figure 2. Excision and integration activities of Sleeping Beauty transposase mutants. (A) Transposon excision assay. A genetically tagged SB transposon
disrupts the GFP coding sequence maintained on a plasmid. Cells transfected with this construct do not express GFP. In the presence of SB transposase
excision occurs, and in a fraction of the products the GFP coding sequence is restored, thereby leading to green fluorescence that can be quantified. (B)
Relative excision efficiencies. Plasmids expressing transposase mutants were transiently cotransfected with a transposon-donor plasmid (pCMV(CAT)-
GFP//T2Neo) into HeLa cells. The frequency of excision is indicated by GFP fluorescence intensity, determined by FACS analysis and normalized to
SB100X. An inactive SB transposase (D3) was included as negative control. Data are represented as mean ± SD, n = 3 biological replicates. Differences
in excision activities are significant as determined by Student’s t-test for K248T P = 0.018, for all other mutants P<0.001. (C) Relative transposition
efficiencies. Plasmids expressing transposase mutants were transiently cotransfected with a transposon-donor plasmid (pT2B/puro) into HeLa cells. Cells
were selected for puromycin resistance and stained with methylene blue to identify viable cell colonies. The frequency of integration is indicated by the
number of puromycin resistant colonies and was normalized to SB100X; D3 was included as negative control. Data are represented as mean ± SD, n =
4 biological replicates. Differences in transposition activities are significant as determined by Student’s t-test for K248R P = 0.012, for all other mutants
P < 0.01.
Both of the transposon excision assays described above
are suitable for quantitative measurement of transposon ex-
cision, but they can only score events associatedwith canon-
ical excision and thus restoration of theGFPor puro coding
sequences. It is concievable that the K248S and K248T mu-
tants have lower scorable excision activities than SB100X
in our assays, because a sizeable fraction of excision events
are imprecise; these excision events would be incompatible
with bothmarker expression and subsequent transposon in-
tegration. Thus, in order to gain a deeper qualitative insight
into the excision reaction catalyzed by the SB transposase
mutants K248S and K248T, we applied a PCR-based as-
say, which is suitable to isolate, amplify and sequence the
transposon excision sites following transient transfection
of transposon donor and transposase expression plasmids
into cultured cells (22) (Figure 5A). We randomly picked
and sequenced 25–30 products representing transposon ex-
cision sites generated by SB100X (positive control) and the
K248S and K248T mutants. Consistent with previous ob-
servations for SB excision in human HeLa cells (79,80),
sequencing of the PCR products revealed some DNA se-
quence heterogeneity at the transposon excision sites gener-
ated by SB100X; alongside with canonical footprints, prod-
ucts displaying deletions at the footprint were also observed
(Figure 5B and Supplementary Figure S4), consistent with
error-prone NHEJ repair at the ends of the broken DNA
following transposon excision (22,79). Excision footprints
generated by the K248S and K248T mutants were indis-
tinguishable from those generated by SB100X (Figure 5B
and Supplementary Figure S4). In addition, we addressed
if the K248S and K248T mutants maintain fidelity of foot-
print formation following excision from a genomic context.
Transgenic HeLa and HepG2 cells containing a single copy
of the SB transposon were transfected with transposase ex-
pression plasmids, and genomic DNA subjected to PCR
with primers flanking the transposon. Sequencing of the
PCR products revealed indistinguishable footprints gener-
ated by SB100X, K248S and K248T displaying the charac-
teristic, canonical junctions of donor DNA following trans-
poson excision (Supplementary Figure S5). We conclude
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Figure 3. Mobilization of a chromosomically integrated Sleeping Beauty transposon. (A) The HeLa-derived reporter cell line contains a single copy of a
piggyBac (PB) transposon carrying a puro antibiotic marker, whose coding sequence is disrupted by an SB transposon carrying a neo expression cassette.
These cells are thus resistant to G418 and sensitive to puromycin. Expression of SB transposases in these cells results in mobilization of the SB transposon
out of the puro marker, thereby reconstituting the puro ORF and resulting in puro resistance. In case the excised transposon does not reintegrate into
the genome the resulting cell will be puro-resistant but G418-sensitive. In case the excised SB transposon reintegrates somewhere else in the genome the
resulting cell will be resistant to both puro and G418. (B) Relative efficiencies of the excision and integration activities of the K248S and K248T mutants.
Positive and negative controls were as decribed in Figure 2. Data are represented as mean ± SD, n = 3 biological replicates. Asterisks indicate significant
differences as determined by Student’s t-test **P < 0.001; ***P < 0.0001.
that excision and footprint formation by the mutants qual-
itatively follow the canonical pathway of SB transposition.
Transposons excised by the K248S and K248T Sleeping
Beauty transposase mutants generate extrachromosomal cir-
cles
To investigate the fate of transposon molecules excised by
K248S and K248T transposases, a circle formation assay
was performed. Earlier work suggested that transposon ex-
cision by the K248A variant generates circular molecules
(59). The ability of the K248S and K248T transposase
mutants to give rise to circular molecules after excision
was determined using a donor plasmid (pT/zeo) that con-
tains a transposon carrying an origin of replication and a
zeocin antibiotic resistance gene (zeo) (70). Following tran-
sient transfection of the transposon/transposase compo-
nents into HeLa cells, non-integrated/circularized transpo-
son molecules can be recovered from low molecular weight
DNA preparation, and transformation into E. coli followed
by zeocin selection (Figure 6A). Assuming canonical trans-
poson excision, the sequences of the transposon end junc-
tions resulting from ligation (circularization) can be pre-
dicted (Figure 6B), and the circles can be detected by PCR.
Figure 6C demonstrates that, unlike SB100X, the mutant
transposases K248S and K248T frequently generate circu-
lar transposon molecules upon excision. Analysis of the
transposon circle junction sequences generated by the trans-
posase mutants K248S and K248T revealed two classes of
products. Some junctions correspond to simple religation
of transposon ends following canonical, precise transposon
excision, whereas other junctions contained five additional
nucleotides (TACAG from the transposon end), which can-
not easily be reconciled with a canonical excision/religation
process (Figure 6D). Regardless of the pathway that gen-
erates these circles, we found that they are unable to un-
dergo transposition by the SB100X transposase when co-
transfected intoHeLa cells (Figure 6E), suggesting that they
represent dead-end products of SB transposition.
Generation of transgene-free induced pluripotent stem cells
by cassette removal with K248T
To explore the applicability of the most effective trans-
posase mutant K248T in transient transgenesis, we de-
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Figure 4. The D246A replacement rescues transposon integration activ-
ity of K248 mutants. Plasmids expressing the indicated single- and double
mutants of the SB100X transposase along with SB100X (positive control)
and catalytically inactive SB transposase (D3, negative control) were tran-
siently cotransfected with a puro-tagged transposon donor plasmid into
HeLa cells. The frequency of integration is indicated by the number of
puromycin-resistant colonies. Data are represented as mean ± SD, n =
3 biological replicates. Asterisks indicate significant differences as deter-
mined by Student’s t-test **P < 0.001.
ployed a previously characterized mouse iPSC line contain-
ing a single SB transposon reprogramming vector inser-
tion on chrX (26). The reprogramming vector contains an
OSKML (Oct4, Sox2, Klf4, c-Myc and Lin28 reprogram-
ming factors) expression cassette driven by the CAG pro-
moter and includes a putk positive/negative selection cas-
sette (Figure 7A). The putk cassette allows positive se-
lection due to resistance to puromycin and negative selec-
tion based on sensitivity to 1-(-2-deoxy-2-fluoro-1-beta-D-
arabino-furanosyl)-5-iodouracil (FIAU). This iPSC line has
been generated in the transgenic OG2 background, which
contains aGFP transgene driven by theOct4 promoter (81).
Thus, iPSCs cells derived from OG2 MEFs express GFP
due to the activation of the Oct4 promoter in pluripotent
stem cells.
Mouse iPSCs were transiently transfected with the SB
transposase K248T and subjected to FIAU selection to
sort for OSKML cassette loss. A diagnostic splinkerette
PCR on genomic DNA prepared from a FIAU-resistant
iPSC clone revealed loss of the transposon in the mouse
genome (Figure 7B). These ‘cassette-removed’ iPSCs ex-
pressed GFP from the Oct4 promoter and expressed the en-
dogenous pluripotency marker nanog (Figure 7C), thereby
indicating that theK248T transposase allows removal of re-
programming genes in iPSCs and that these cells maintain
pluripotency even in the absence of external pluripotency
factors.
DISCUSSION
Here we conducted a mutagenesis screen in the SB trans-
posase, and identified two novel mutants, K248S and
K248T, that exhibit an exc+/int− phenotype. In the transpo-
sition reactions catalyzed by these transposase variants the
excision and integration functions are clearly disconnected,
Figure 5. Analysis of excision footprints by plasmid-based excision as-
say. (A) Schematic of the plasmid-based excision assay. HeLa cells were
transfected with a puromycin-marked (Puro) donor plasmid along with a
transposase-encoding expression plasmid. The gap in the donor-plasmid
left by the transposon is re-ligated and leaves a footprint at the site of
the initial transposon. Two days post-transfection, plasmid DNA was iso-
lated from cells, and analyzed in nested PCR reactions to determine the
footprints of the excision reactions. (B) Excision footprints generated by
SB100X, K248S and K248T. Footprints are shown in bold.
displaying high efficiency transposon excision with no de-
tectable level of re-integration in human cells.
Regions within the catalytic core domain of retroviral in-
tegrases and theTn10 transposase have been shown to be in-
volved in mediating interactions with the target DNA (82–
84), and are thus critically important for genomic integra-
tion. K248 is situated directly C-terminal to the D244 cat-
alytic residue (the second D in the DDE triad) in the SB
transposase (Figure 1C). This region is analogous to the
2 helix in HIV integrase, which was shown to be required
for retroviral integration (82,83). In addition, the proxim-
ity of K248 to target DNA in the SB TCC model (Figure
1C) suggests that the defect underlying the int− phenotype
is related to a reduced ability of the transposase to either in-
teract with the target DNA or perform strand transfer. No-
tably, the previously reported exc+/int− PB mutants were
also replacements of conserved, positively charged amino
acids (lysines and arginines) in the catalytic core domain of
the transposase (58), and exc+/int− Tn10 transposase mu-
tants were shown to be defective in target DNA capture
(84).
Amino acid sequence alignments revealed a distinct
group of Tc1 family transposases that do not contain the
characteristicD246/K248 amino acid dyad (Figure 1A).We
have shown that a D246A replacement can fully rescue in-
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Figure 6. The K248S and K248T Sleeping Beauty transposase mutants generate transposon circles. (A) SB transposon circle donor plasmid (pT/zeo) and
SB transposase-generated transposon circle. The transposase (green circle) binds to the left and right TIRs (LIR and RIR), and catalyzes the excision of
the transposable element from the donor plasmid. DNA breaks at the donor site are repaired by the host DNA repair machinery. (B) Expected junction
sequence after precise transposon excision and circularization of the donor plasmid. The central T:T mismatch is expected to be resolved by mismatch
repair to yield a CTGorCAG sequence. (C) PCR-based circle formation assay. HeLa cells were transfected with a transposase expression plasmid (SB100X,
K248S, K248T) along with the transposon donor plasmid pT/zeo. Circularized excised transposon molecules were recovered from low molecular weight
DNA preparation followed by transformation into E. coli and zeocin selection. Twenty individual E. coli colonies from each transposase group were
subjected to PCR to detect a circularized transposon, revealed by a ∼300-bp band. The positions of the 300-bp size marker are indicated on the left.
(D) Analysis of transposon circle junction sequences. Sequences of independent transposon circle junctions generated by K248S or K248T. On top, the
expected junction sequence formed after canonical transposon excision and religation is shown. (E) Transposon circles do not support SB transposition.
Some of the products generated by K248S and K248T and pT/zeo (positive control) were re-introduced into HeLa cells together with SB100X or with D3
(negative control) and zeocin-resistant cell colonies were counted. Data are represented as mean ± SEM, n = 3 biological replicates.
tegration activity of K248S and K248T (Figure 4). Because
the D246A mutation in itself is detrimental to SB transpo-
sition (59), these results establish an epistatic relationship
between amino acid residues in positions 246 and 248 dur-
ing transposition. All transposase sequences that contain K
in position 248 have D in position 246. K248 is positioned
near D246 and both residues are located on the target
DNA binding surface of SB in our TCC model. Thus, it is
tempting to speculate that in D246/K248-containing trans-
posases, the positively charged side chain of K248 shields
the negative charge of D246 to prevent charge repulsion
with the target DNA. Removal of K248 would expose the
negative charge of D246, largely compromising target DNA
binding. Simultaneous mutation of K248 and D246 would
negate the charge conflict and could rescue transposition.
This is consistent with the conservation of A246 in trans-
posases that lack K248 and rescue of transposition activity
in SB double mutants.
Excision by the K248S and K248T SB transposases leads
to production of sealed transposon circles (Figure 6C),
which cannot proceed to integration (Figure 6E), stalling
the transposition reaction after excision. Intriguingly, se-
quence analysis of transposon circles suggests an alternative
mode of excision by the K248S andK248T SB transposases
by a mechanism, in which initially exposed 3′-OHs attack
the complementary strands to form hairpins on the trans-
poson ends with concomitant release from the donor DNA.
This alternative pathway would result in canonical foot-
prints at donor sites, whereas hairpin resolution at a shifted
position can explain the extended junction sequences (Sup-
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Figure 7. Reprogramming cassette removal with K248T in mouse induced pluripotent stem cells. (A) Transient transgenesis with an SB vector containing
reprogramming genes and their removal with transient expression of the K248T SB transposase. Schematic representation of the SB transposon-based
reprogramming vector pT2-CAG.OSKML-putk (26). Individual genes in five-factor cassettes were linked by 2A self-cleaving peptide sequence and ex-
pressed from the CAGpromoter. Black arrows represent SB transposon TIRs; pA, bovine growth hormone polyadenylation signal; putk, PGKpromoter-
driven putk expression cassette. TheOSKML factors plus selection genes were removed from a single-copymouse iPSC clone with the help of the SB100X
transposase mutant K248T. (B) Linker-mediated PCR genotyping of a mouse iPSC clone before and after cassette removal. The lack of a PCR product
in lane 2 of the agarose gel indicates that the reprogramming cassette was successfully removed with K248T (top gel). The quality of the genomic DNAs
was verified by control PCR using GAPDH primers (bottom gel). (C) Phenotyping of a reprogramming factor-free mouse iPSC clone. Reprogramming
factor-free mouse iPSCs express the endogenous nanog pluripotency marker (immunostaining) and GFP from the endogenous Oct4 promoter. Scale bar:
50 m.
plementary Figure S6). Importantly, it has recently been
shown that all the chemical steps of mariner transposition
are executed by a single transposase dimer, in which one
monomer performs two sequential strand cleavage and one
strand transfer reactions at the same transposon end (85),
thereby providing strong evidence that a single DDE/D
active site can hydrolyze DNA strands of opposite polar-
ity. The mariner transposase cleaves the non-transferred
strand first (21), and we infer that the first cleavage event
during wild-type SB transposition also occurs at the non-
transferred strand of the SB transposon. It is conceivable
that the K248S andK248Tmutations convert the active site
into one that cleaves only one strand, and a hairpin on the
transposon end generated by K248S and K248T implies a
nick at the transferred strand (Supplementary Figure S6),
just like in Tn5, Tn10 and piggyBac transposition (12–14).
Alternatively, the footprints of transposon excision (Figure
5B) and circularization (Figure 6D) may be explained with
altered cleavage position by theK248S andK248Tmutants,
but the exact sites are difficult to predict in the absence of a
robust in vitro excision reaction.
Circularization of excised DNA without subsequent ge-
nomic integration is reminiscent of V(D)J recombination in
the immune system of jawed vertebrates [reviewed in (86)].
In this process, that occurs during lymphocyte develop-
ment, pre-existing V (variable), D (diversity), and J (join-
ing) gene segments are rearranged to generate a large reper-
toire of T-cell surface receptor (TCR) and immunoglob-
ulin molecules necessary for the recognition of diverse
pathogens. The recombination event involves cis-acting se-
quences known as recombination signal sequences (RSSs)
(functional equivalents of transposon TIRs) that flank each
receptor gene segment and requires two proteins encoded
by the recombination-activating genes, RAG1 and RAG2
(functional equivalents of a transposase). The V(D)J re-
combination reaction is subdivided into two stages, a cleav-
age phase and a joining phase [reviewed in (86)]. The com-
plex formed by the RAG1 and RAG2 proteins introduces
DSBs in the DNA between the RSS and the neighboring
coding DNA via a nick-hairpin mechanism (Supplemen-
tary Figure S7). This mechanism shares significant similari-
ties with the excision step of the cut-and-paste transposition
process (87), with the fundamental difference that the DNA
sequence elements excised byRAG1/RAG2donot undergo
genomic integration. Repair factors of the NHEJ pathway
join the two signal ends resulting in circular, extrachromo-
somal circles (signal joints), which are lost from the cell
(Supplementary Figure S7). Both of the RAG proteins have
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been proposed to originate from a transposon (88,89), and
are thought to have undergone a ‘domestication’ process,
during which the ancestral transposon/transposase com-
ponents have acquired regulatory components suppress-
ing genomic integration of excised DNA (90). Remark-
ably, the DNA transposition reactions catalyzed by our
new K248S and K248T SB transposases resemble a V(D)J
recombination-like process, with excision resulting in sealed
transposon circles and no re-integration (Supplementary
Figure S7). Thus, it is tempting to speculate that one of the
early evolutionary adaptations that gave rise to the domes-
ticated RAG1 recombinase might have been amino acid re-
placementmutations, similar to the ones that we report here
for the SB transposase, in the ancestral RAG transposase
some 500million years ago, resulting in an exc+/int− pheno-
type, which has undergone fixation and has been under se-
lection ever since. Indeed, recent evidence highlights the im-
portance of anM848R replacement in an ancestor ofRAG1
that, together with an acidic region in RAG2, dramatically
suppresses RAG-mediated transposition (91). Importantly,
an inverse (R848M) mutation converts RAG1 into an ac-
tive transposase by stimulating the transposition reaction
at a post-cleavage step (91).
RAG1 is not the only example for a transposase-derived
protein, whose domestication likely involved the loss or
severe repression of integration after transposon excision.
Oxytricha trifallax, a unicellular, ciliated protozoan, has
two types of nuclei in the same cytoplasm.Diploidmicronu-
clei are transcriptionally silent during vegetative growth
but transmit the germline genome through sexual conju-
gation. Macronuclei, on the other hand, govern somatic
gene expression but undergo degradation, so that the new
macronuclei develop from germline micronuclei. Macronu-
clear development in Oxytricha involves deletion of thou-
sands of copies of germline transposons (92), designated
telomere-bearing elements (TBEs) (93). These DNA se-
quences are thus restricted to the micronucleus and absent
in the macronucleus. TBEs encode a transposase character-
ized by a DDE catalytic motif (94). It has been shown that
the TBE transposase generates transposon circles upon ex-
cision, suggesting that circle formation and suppression of
genomic re-integration might be linked (95), and that the
TBE transposase has been domesticated to serve as an ‘ex-
cisase’ during macronuclear development in Oxytricha.
A third example for a DNA recombination reaction
where the production of episomal circles have been ob-
served is retroviral integration [reviewed in (96)]. Some
of the linear double-stranded DNA resulting from reverse
transcription during the retroviral- and lentiviral life cycle
is converted into circular episomes by cellular DSB repair
factors. During this process, NHEJ generates 2-LTR circles,
whereas homologous recombination (HR) generates 1-LTR
circles, both containing the entire viral genome and either
two or one LTRmotifs, respectively. The formation of retro-
viral circles negatively correlates with the ability of the virus
to integrate into the host genome. For example, mutations
in the retroviral integrase DDE residues (such as D64V in
the case of lentiviral vectors) that block proviral integration
result in enhanced levels of retroviral circles. This observa-
tion served as a basis for the development of integration-
deficient lentiviral vectors (IDLVs) that are typically used
for the generation of circular vector episomes in transduced
cells for various genetic engineering applications [reviewed
in (96,97)].
The wild-type, fully competent SB transposase can also
generate transposon circles, albeit at a rather low frequency
(Figure 6C), implying that transposon integration and cir-
cle formation are competitive processes. Indeed, circulariza-
tion of DNA following excision by the K248S and K248T
SB transposase mutants, during V(D)J recombination and
TBE transposon excision in the Oxytricha macronucleus
and in IDLVs collectively point to a general rule, in which in
the absence of genomic integrationDNA repair factors gain
access to the ends of extrachromosomal, linear fragments
of DNA, thereby leading to the formation of circles. In the
case of SB transposition it is clear that these circles cannot
be substrates for a new round of cut-and-paste transposi-
tion (Figure 6E), thus representing dead-end side products
of the transposition reaction.
We demonstrated the utility of the SB transposase mu-
tants in ‘transient transgenesis’ for the generation of repro-
gramming factor-free iPSCs (Figure 7). The key attributes
of these mutants that match the requirements of applica-
tions as genetic tools include efficient excision (Figure 2)
and canonical footprint formation (Figure 4). Although the
amino acid substitutions in our mutants have a clearly neg-
ative impact on the efficiency of excision (Figures 2B and
3B), we note that these mutants have been generated in the
SB100X hyperactive transposase background. Thus, the net
efficiency of excision by our mutants still enables efficient
generation of ‘transgene-free’ cells, especially in experimen-
tal situations where clonal cell propagation is possible (e.g.
in iPSC culture, as demonstrated here). The benefit of ap-
plying ‘transient transgenesis’ by these SB variants might
be best realized in genetic backgrounds that limit efficient
reprogramming by non-integrating technologies, including
fibroblasts from patients with ataxia telangiectasia (98,99).
Finally, because the K248 residue of the SB transposase is
proposed to be involved in interaction with the target DNA,
some of the integration-proficient mutants that we gener-
ated in our screen (Figure 2) might display alterations in
genome-wide target site selection properties, thereby pro-
viding a useful resource for future structure-function inves-
tigations of SB transposition.
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